129 related articles for article (PubMed ID: 2474731)
1. Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes?
Galili U
Lancet; 1989 Aug; 2(8659):358-61. PubMed ID: 2474731
[TBL] [Abstract][Full Text] [Related]
2. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
Galili U; Shohet SB; Kobrin E; Stults CL; Macher BA
J Biol Chem; 1988 Nov; 263(33):17755-62. PubMed ID: 2460463
[TBL] [Abstract][Full Text] [Related]
3. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Galili U
Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
[TBL] [Abstract][Full Text] [Related]
4. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells.
Thall A; Etienne-Decerf J; Winand RJ; Galili U
Autoimmunity; 1991; 10(2):81-7. PubMed ID: 1723633
[TBL] [Abstract][Full Text] [Related]
5. The alpha-galactosyl epitope on mammalian thyroid cells.
Thall A; Etienne-Decerf J; Winand RJ; Galili U
Acta Endocrinol (Copenh); 1991 Jun; 124(6):692-9. PubMed ID: 1712528
[TBL] [Abstract][Full Text] [Related]
6. Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
Repik PM; Strizki JM; Galili U
J Gen Virol; 1994 May; 75 ( Pt 5)():1177-81. PubMed ID: 7513744
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay.
Thall A; Galili U
Biochemistry; 1990 Apr; 29(16):3959-65. PubMed ID: 2354167
[TBL] [Abstract][Full Text] [Related]
8. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
9. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
10. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.
Galili U; Swanson K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7401-4. PubMed ID: 1908095
[TBL] [Abstract][Full Text] [Related]
11. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
Galili U
J Mol Evol; 2015 Jan; 80(1):1-9. PubMed ID: 25315716
[TBL] [Abstract][Full Text] [Related]
12. Mosquito vector proteins homologous to α1-3 galactosyl transferases of tick vectors in the context of protective immunity against malaria and hypersensitivity to vector bites.
Ramasamy R
Parasit Vectors; 2021 Jun; 14(1):303. PubMed ID: 34090497
[TBL] [Abstract][Full Text] [Related]
13. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
14. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the expression of Gal alpha 1-3Gal beta 1-4GlcNAc glycosphingolipids in kidney.
Hendricks SP; He P; Stults CL; Macher BA
J Biol Chem; 1990 Oct; 265(29):17621-6. PubMed ID: 2211651
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
[TBL] [Abstract][Full Text] [Related]
18. Isolation of the feline alpha1,3-galactosyltransferase gene, expression in transfected human cells and its phylogenetic analysis.
Roy BB; Jinno-Oue A; Shinagawa M; Shimizu A; Tamura K; Shimizu N; Tanaka A; Hoshino H
J Exp Zool B Mol Dev Evol; 2006 Jan; 306(1):59-69. PubMed ID: 16217797
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
LaTemple DC; Henion TR; Anaraki F; Galili U
Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.
Galili U; Clark MR; Shohet SB; Buehler J; Macher BA
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1369-73. PubMed ID: 2434954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
